Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-136530 |
Brand: | MCE |
CAS: | 2505001-62-5 |
MDL | - |
---|---|
Molecular Weight | 420.31 |
Molecular Formula | C16H19Cl2N3O4S |
SMILES | ClC1=CC(/C=C/C(NCC(N2CCN(CC2)S(C)(=O)=O)=O)=O)=CC=C1Cl |
IC50: 4.4 nM (KLF5) [1]
SR18662 (0-10 μM; 24-72 hours) significantly reduces growth and proliferation of CRC cells as compared to treatment with vehicle control, ML264 (HY-19994). It shows improved efficacy in reducing viability of multiple CRC cell lines
[1]
.
SR18662 (10 μM; 24-72 hours) shows a significant increase in the number of apoptotic cells at both early and late states in DLD-1 and HCT116 cells
[1]
.
SR18662 (1 μM; 72 hours) reduces the expression of cyclins (cyclins E, A2, and B1) and components of MAPK (p-Erk) and WNT signaling pathways (p-GSK3 β) in cells
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
Cell Line: | CRC cells |
Concentration: | 0-10 μM |
Incubation Time: | 24 hours, 48 hours, 72 hours |
Result: | Induced anti-tumor activity in colorectal cancer cell lines. |
Apoptosis Analysis [1]
Cell Line: | DLD-1 and HCT116 cells |
Concentration: | 10 μM |
Incubation Time: | 24 hours, 48 hours, 72 hours |
Result: | Increased apoptosis of colorectal cancer cell lines. |
Western Blot Analysis [1]
Cell Line: | DLD-1 and HCT116 cells |
Concentration: | 1 μM |
Incubation Time: | 72 hours |
Result: | Reduced levels of cyclins E, A2, and B1 inhibits activity of MAPK, WNT/β-catenin signaling pathways and decreases the levels of cyclins. |
SR18662 (intraperitoneal injection; 5-10 mg/kg; daily or twice daily; 5 days injection, days break, and 5 days) significantly reduces the growth of tumors in a mouse xenograft model
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Nude mice with DLD-1 cells [1] |
Dosage: | 5 mg/kg; 10 mg/kg; 25 mg/kg |
Administration: | Intraperitoneal injection; 5mg/kg daily, 5mg/kg twice a day,10 mg/kg daily, 10 mg/kg twice per day, 25mg/kg daily, and 25 mg/kg twice per day; 5 days of injections, 2 days break, and 5 days of injections |
Result: | Caused a significant dose-dependent inhibition of xenograft growth in mice. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 125 mg/mL ( 297.40 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.3792 mL | 11.8960 mL | 23.7920 mL |
5 mM | 0.4758 mL | 2.3792 mL | 4.7584 mL |
10 mM | 0.2379 mL | 1.1896 mL | 2.3792 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.